Skip to main content
. 2023 Sep 27;16:2677–2686. doi: 10.2147/CCID.S427956

Figure 3.

Figure 3

Four representative participants at baseline and Week 2 and/or Week 12 after Dark Spot Tx. (A) A 37-year-old woman with Fitzpatrick skin type IV and PIH. (B) A 25-year-old woman with Fitzpatrick skin type V and PIH. (C) A 64-year-old woman with Fitzpatrick skin type II and solar lentigines. (D) A 51-year-old woman with Fitzpatrick skin type IV and solar lentigines.